What intrigued me was how new the entity is. New website (and private registration), new Twitter account, not yet even listed on the list of companies at the techno Park in Spain, etc. And yet they claim to have been instrumental in promoting the success of C1.
Maybe a BDI spin-off that has been in sleath mode until now? Or perhaps simply a name change?
I find it very encouraging that they'd spin-off a separate brand to focus on pharma with C1. Looking forward to a steady flow of progress on both the scientific and commercial fronts.